HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

zalutumumab

directed against epidermal growth factor receptor for treatment of squamous cell cancer of head and neck
Networked: 10 relevant articles (1 outcomes, 2 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Parren, Paul W H I: 4 articles (01/2012 - 10/2008)
2. Bleeker, Wim K: 3 articles (05/2014 - 01/2010)
3. van de Winkel, Jan G J: 3 articles (09/2011 - 10/2008)
4. Lammerts van Bueren, Jeroen J: 3 articles (09/2011 - 10/2008)
5. Lisby, Steen: 2 articles (06/2014 - 04/2011)
6. Houtkamp, Mischa: 2 articles (05/2014 - 01/2012)
7. van den Brakel, Jeroen H: 2 articles (05/2014 - 09/2011)
8. Saloura, Vassiliki: 1 article (06/2014)
9. Licitra, Lisa: 1 article (06/2014)
10. Gauler, Thomas C: 1 article (06/2014)

Related Diseases

1. Neoplasms (Cancer)
2. Head and Neck Neoplasms (Head and Neck Cancer)
3. Squamous Cell Neoplasms (Squamous Cell Cancer)
4. Colorectal Neoplasms (Colorectal Cancer)
5. Exanthema (Rash)

Related Drugs and Biologics

1. Epidermal Growth Factor Receptor (EGF Receptor)
2. Monoclonal Antibodies
3. ofatumumab
4. zanolimumab
5. panitumumab (Vectibix)
6. Platinum
7. nimotuzumab
8. lapatinib (GW572016)
9. gefitinib (Iressa)
10. cetuximab (Erbitux)

Related Therapies and Procedures

1. Therapeutics
2. Subcutaneous Injections